Therefore, regulation of STAT3 and SOCS3 in the FLS of patients with RA through the IL-6/gp130/STAT3 signaling pathway might be a potent therapeutic strategy in the treatment of RA. Here, SOCS3 is linked to rheumatoid arthritis.